Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

A new wave of COVID-19 cases, driven by the JN.1 Omicron sub-variant, is emerging in parts of Asia, raising global concerns.

At present, government data shows 257 active COVID-19 cases across various states in the country, with most of them coming ...

The JN.1 variant is a newer version of the coronavirus that comes from the Omicron BA.2.86 family. It was first found in ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

The Ministry of Health and Family Welfare reviews the recent COVID-19 surge in Singapore and Hong Kong. India reports 257 ...

The JN.1 variant is a descendant of the Omicron BA.2.86 lineage. First discovered in August 2023, JN.1 “has acquired the ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...